End Cash: The amount of cash held by the company for the given period.
Beta Bionics, Inc. (BBNX) had End Cash of $38.59M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$27.25M |
|
$-14.21M |
|
$12.13M |
|
$15.12M |
|
$44.30M |
|
$-17.04M |
|
$2.83M |
|
$-14.21M |
|
$-14.21M |
|
$-14.21M |
|
$-14.21M |
|
$-14.21M |
|
$-14.21M |
|
$-17.04M |
|
$-16.36M |
|
43.63M |
|
43.63M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$270.03M |
|
$7.38M |
|
$60.02M |
|
$330.05M |
|
$25.39M |
|
-- |
|
$9.90M |
|
$35.29M |
|
$294.76M |
|
$294.76M |
|
$294.76M |
|
43.99M |
|
| Cash Flow Statement Financials | |
$-42.30M |
|
$-163.46M |
|
$213.81M |
|
$30.53M |
|
|
End Cash |
$38.59M |
$8.05M |
|
$12.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
55.48% |
|
-62.54% |
|
-62.54% |
|
-- |
|
-52.14% |
|
-52.14% |
|
$-45.69M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.60 |
|
2.36 |
|
38.11 |
|
-4.82% |
|
-4.82% |
|
-4.31% |
|
-4.82% |
|
$6.70 |
|
$-1.05 |
|
$-0.97 |
|